Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?

被引：0
|
作者：
Claire L. Jansson-Knodell
Courtney E. Harris
Edward V. Loftus
Randall C. Walker
Mark J. Enzler
Abinash Virk
机构：
[1] Indiana University,Division of Gastroenterology and Hepatology
[2] Mayo Clinic,Department of Internal Medicine
[3] Mayo Clinic,Division of Gastroenterology and Hepatology
[4] Mayo Clinic,Division of Infectious Diseases
来源：
Digestive Diseases and Sciences | 2021年 / 66卷
关键词：
Fungal infection; Infliximab; Adalimumab; Certolizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：190 / 198
页数：8
相关论文
共 50 条
  • [31] Tumor necrosis factor alpha gene polymorphisms in relation to inflammatory bowel disease
    Stokkers, PCF
    Reitsma, PH
    Tytgat, GNJ
    vanDeventer, SJH
    GASTROENTEROLOGY, 1997, 112 (04) : A1098 - A1098
  • [32] Systematic Review and Meta-Analysis: Risks of Postoperative Complications With Preoperative Use of Anti-Tumor Necrosis Factor-Alpha Biologics in Inflammatory Bowel Disease Patients
    Moosvi, Zain
    Duong, Jacqueline
    Nguyen, Douglas
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S389 - S389
  • [33] Systematic review and meta-analysis: risks of postoperative complications with preoperative use of anti-tumor necrosis factor-alpha biologics in inflammatory bowel disease patients
    Moosvi, Zain
    Duong, Jacqueline
    Bechtold, Matthew L.
    Nguyen, Douglas L.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (06) : 799 - 816
  • [34] Thalidomide analogues: Tumor necrosis factor-alpha inhibitors and their evaluation as anti-inflammatory agents
    Jose Casal, Juan
    Bollini, Mariela
    Elisa Lombardo, Maria
    Maria Bruno, Ana
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 83 : 114 - 119
  • [35] Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn's disease
    Bor Renata
    Farkas Klaudia
    Balint Anita
    Szucs Monika
    Abraham Szabolcs
    Baradnay Gellert
    Wittmann Tibor
    Szepes Zoltan
    Nagy Ferenc
    Molnar Tamas
    ORVOSI HETILAP, 2013, 154 (49) : 1943 - 1948
  • [36] Mucosal and Histologic Healing in Children With Inflammatory Bowel Disease Treated With Antitumor Necrosis Factor-Alpha
    Scarallo, Luca
    Alvisi, Patrizia
    Bolasco, Giulia
    Di Toma, Michele
    Lanari, Marcello
    Cangiari, Alice
    Paci, Monica
    Naldini, Sara
    Renzo, Sara
    Barp, Jacopo
    De Masi, Salvatore
    Lionetti, Paolo
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2021, 72 (05): : 728 - 735
  • [37] Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases
    Ward, Daniel
    Andersen, Nynne Nyboe
    Gortz, Sanne
    Iversen, Aske Thorn
    Allin, Kristine Hojgaard
    Beaugerie, Laurent
    Kirchgesner, Julien
    Jess, Tine
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (01) : 135 - 143.e8
  • [38] Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors
    Solomon, Andrew J.
    Spain, Rebecca I.
    Kruer, Michael C.
    Bourdette, Dennis
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (12) : 1472 - 1487
  • [39] Failure Rate of Antitumor Necrosis Factor Alpha Biologics in Very Early Onset Inflammatory Bowel Disease
    Collen, Lauren, V
    Snapper, Scott B.
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (03) : 513 - 514
  • [40] Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk
    Lynnette R Ferguson
    Claudia Huebner
    Ivonne Petermann
    Richard B Gearry
    Murray L Barclay
    Pieter Demmers
    Alan McCulloch
    Dug Yeo Han
    World Journal of Gastroenterology, 2008, (29) : 4652 - 4661
12345